Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 5/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL225702 | 1.00 | TSHR (0.71) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL23046863 | 0.97 | TSHR (0.77) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL20387044 | 0.92 | TSHR (0.63) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL1163970 | 0.91 | TSHR (0.67) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL6828156 | 0.88 | TSHR (0.67) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL1163365 | 0.88 | TSHR (0.67) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL1673083 | 0.88 | TSHR (0.67) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL1163681 | 0.88 | TSHR (0.67) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL931298 | 0.88 | TSHR (0.67) | TSHRLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL4459033 | 0.88 | TSHR (0.55) | TSHRLMNASLC22A6NFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 953 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118001240-B | Podophyllotoxin-9-fluorenylmethanol small molecule prodrug nanoparticle and preparation method and application thereof | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20250361441-A1 | ETCHING COMPOSITION, ETCHING METHOD, METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND METHOD FOR MANUFACTURING GATE-ALL-AROUND-TYPE TRANSISTOR | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-11-27 | — | — | US | claimed |
| US-20250325513-A1 | CABAZITAXEL PRODRUG ANTI-TUMOR PREPARATION | UNIV SHENYANG PHARMACEUTICAL (CN) | 2025-10-23 | — | — | US | claimed |
| US-12419551-B2 | Mediation of in vivo analyte signal degradation | SENSEONICS, INCORPORATED (US) | 2025-09-23 | — | — | US | claimed |
| EP-4590782-A1 | GAS-PHASE COMPOSITION FOR INHIBITING CORROSION EXPOSED TO CONDENSED WATER | Arkema France (FR) | 2025-07-30 | — | — | EP | claimed |
| CN-120039004-A | Lightweight anti-tearing PVC (polyvinyl chloride) lamp box cloth | 山东汇锋新材料有限公司 | 2025-05-27 | — | — | CN | claimed |
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025074986-A1 | MODIFIED POLYCARBONATE, METHOD FOR PRODUCING MODIFIED POLYCARBONATE, AND RESIN COMPOSITION | 株式会社カネカ | 2025-04-10 | — | — | WO | claimed |
| EP-3965657-B1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | SENSEONICS INC (US) | 2025-03-05 | — | — | EP | claimed |
| CN-119531139-A | Wear-resistant and soil-release case fabric and processing method thereof | 南通友途新材料科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| EP-0675712-A1 | REDUCTION OF HAIR GROWTH EMPLOYING SULFHYDRYL REACTIVE COMPOUNDS | HANDELMAN, Joseph H. (US) | 1995-10-11 | — | — | EP | claimed |
| US-5411991-A | Applying to human skin, beards, reaction with cysteine | GILLETTE COMPANY, THE, A DELAWARE CORPORATION | 1995-05-02 | — | — | US | claimed |
| EP-0635548-A1 | Thermoplastic resin composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 1995-01-25 | — | — | EP | claimed |
| WO-1994014428-A1 | REDUCTION OF HAIR GROWTH EMPLOYING SULFHYDRYL REACTIVE COMPOUNDS | HANDELMAN, JOSEPH, H. (US) | 1994-07-07 | — | — | WO | claimed |
| EP-0497810-B1 | TONE CONTROLLING COMPOUNDS | KODAK LTD (GB) | 1994-06-08 | — | — | EP | claimed |
| EP-0579089-A1 | Polyether ester amide-sulfur vulcanized rubber compounds | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1994-01-19 | — | — | EP | claimed |
| US-5239004-A | A curied addition-condensation copolymer grafted by at least one dithiodiacid; odorless, stiffness, tensile strength | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1993-08-24 | — | — | US | claimed |
| EP-0549977-A1 | Carboxyl-containing polyphenylene sulfide, process for producing the same, and resin composition containing the same | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1993-07-07 | — | — | EP | claimed |
| US-4377418-A | Particulate filler, coated with material bonded thereto and containing a sulfur-containing group which releases sulfur as a curing agent for s-curable unsaturated polymers | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1983-03-22 | — | — | US | claimed |
| EP-0038620-A2 | Particulate filler and polymer composition containing the filler | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-10-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419551-B2 | Mediation of in vivo analyte signal degradation | SLC2A1, TXN2, SLC2A8 | TSHR 1204/4885LMNA 4443/4885SLC22A6 569/4885 |
| US-20250325513-A1 | CABAZITAXEL PRODRUG ANTI-TUMOR PREPARATION | FASN, EBP, CTNNB1 | TSHR 4608/4885LMNA 217/4885SLC22A6 1612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.